Stay updated on Fevipiprant in COPD With Eosinophilia Clinical Trial
Sign up to get notified when there's something new on the Fevipiprant in COPD With Eosinophilia Clinical Trial page.

Latest updates to the Fevipiprant in COPD With Eosinophilia Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference4%
- Check16 days agoChange DetectedPage now shows revision to v3.1.0 and removes several drug-safety-related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a shift away from those topics while adding a new version.SummaryDifference0.4%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%
- Check38 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%
- Check45 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location in Hanover, Germany, along with new topics related to drug safety and pathological conditions. Notably, the previous version's references to certain diseases and locations have been removed.SummaryDifference3%
- Check59 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
Stay in the know with updates to Fevipiprant in COPD With Eosinophilia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fevipiprant in COPD With Eosinophilia Clinical Trial page.